CRYSTAGEN 20 MG

Description

DESCRIPTION

Crystagen 20mg is a short synthetic peptide (Glu-Asp-Pro) belonging to the family of regulatory oligopeptides studied for their interaction with immune-tissue cells. Mechanistic interest centers on the peptide’s small size and charged residue profile, which allow it to associate with cellular and nuclear components in in vitro models. Research literature on this class of peptides examines hypothesized templated binding to DNA promoter regions and the modulation of transcriptional activity in cultured cells. Crystagen is supplied strictly as a reference material for laboratory investigation of these molecular interactions.

RESEARCH AREAS

• Peptide–nucleic acid association studied in cell-free and cultured-cell systems
• Transcriptional and gene-expression modulation in immune-lineage cell models
• Short-peptide signaling pathways relevant to lymphoid tissue cultures
• Structure–activity relationships of Glu/Asp/Pro tripeptide motifs

WHAT RESEARCHERS LOOK AT

• Reconstitution behavior and peptide stability in aqueous buffer over time
• Binding affinity assays in cell-free preparations
• mRNA and protein expression readouts in cultured immune-lineage cells
• Dose-range and concentration mapping within in vitro experimental models

QUICK SPECS

• Form: Lyophilized powder
• Net per vial: 20mg
• Purity: ≥98% (HPLC)
• Identity: Confirmed by mass spectrometry
• Storage: Store lyophilized at -20°C; protect from light and moisture

IDENTITY BASICS

• Type: Synthetic tripeptide (Khavinson-class short peptide)
• Sequence/Formula: Glu-Asp-Pro (EDP); C₁₄H₂₁N₃O₈
• Molecular weight: ~359.33 g/mol
• CAS: Not assigned

SELECTED RESEARCH

• PubMed: Peptide regulation of gene expression and protein synthesis
• PubMed: Peptide bioregulation research
• PubMed: Short peptides and DNA binding
• PubChem: Glu-Asp-Pro tripeptide

⚠️ DISCLAIMER

• For laboratory and research use only.
• Not for human or veterinary use; not a drug, food, or cosmetic.
• Not intended to diagnose, treat, cure, or prevent any disease.
• Handling restricted to qualified research personnel in an appropriate setting.